首页 正文

Naoxintong capsule as adjunctive therapy in ACS: a hypothesis-generating open-label randomized trial

{{output}}
Objective: To evaluate, in an exploratory setting, the safety of adjunctive Naoxintong Capsule (NXT) added to standard secondary prevention in patients with acute coronary syndrome (ACS), and to describe between-group differences... ...